Modern SUS has become more adopted by the industry from the mid-2000s with almost all bioprocessing equipment available as a SUS. Multiple SUS bioreactor-based systems in parallel, or even a single system, can compete with stainless steel and produce enough to supply commercial markets at a certain scale. The advances in this technology are cost-effective to support pre-commercial manufacturing for preclinical and clinical supplies.
Join us to learn the ultimate benefits of SUS and the regulatory set in Latinamerica towards the use of this technology that benefits the dynamic of the bioprocesses in the industry.
Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Speaker Board
Marisol Morales Miron
Pesticides and Plant Nutrients Manager
Selene Rodríguez Martínez
Executive Deputy Director for Sanitary Licenses
Matthias Reher
Manager Validation Services
Tonatiuh Cortes Esquivel
Technology Transfer and Optimization Manager
Yuly Natalia Cañón Pérez
Assistant Manager
Luis Alfredo Hernandez Gonzalez
Validation Manager
Yimy Mena
CEO/Director of Process Development
Ihatanderson Alves da Silva
Inspection Office Adviser
Jefferson Garofano
Engineering / Maintenance / Safety and Health Manager
Tobias Voelkel
Confidence® Validation Services Leader
Ricardo Castro
VP of Bioprocessing
Program at a Glance
Single-use Process Equipment: Understanding Regulatory Expectations for Validation Strategy.
Regulatory Parity in Single-use Component Validation
(COFEPRIS, INVIMA, ANVISA, PDA)
Best Practices in Process Safety: Practical Aspects of Sterilizing Grade Filter Validation in the Light of GMP
(Filtration and Fluid Management Technologies)
Process Validation
Challenges: Building Production Plants with Different Requirements (SS vs SUS)
(COFEPRIS, INVIMA, ANVISA)
Success Story
Case Study
Round Table: Key Factors for Successful Validation
Full programme in the PDF Agenda
Download Agenda